European Transfusion Practice and Outcome Study
- Conditions
- SurgeryAnemiaHabitsBlood Coagulation DisordersErythrocyte Transfusion
- Registration Number
- NCT01604083
- Lead Sponsor
- European Society of Anaesthesiology
- Brief Summary
The aim of the ETPOS study is to describe differences in transfusion habits throughout Europe and to correlate these habits to perioperative outcome parameters. Special focus is put on the number of PRBCs (packed red blood cells) transfused and the ratio of PRBCs to other blood products or coagulation factors in the operating room. Furthermore the motivation of physicians to transfuse PRBC and blood products in the operating room will be investigated.
- Detailed Description
In European patients undergoing elective non-cardiac surgery receiving at least one PRBC(packed red blood cells) during their surgery it is proposed to:
1. Evaluate evidence of differences in the standard of peri-operative transfusion care in different healthcare systems within Europe, and the use of blood conserving techniques.
1. Evaluate the ratio of transfusion of PRBC to blood products in the operating room
2. Evaluate which factors determine transfusion of PRBC (is it patient's haemodynamics / haemoglobin threshold/ pressure from the surgeon / acute brisk bleeding / else) and blood products (ratio to PRBC / POC (point of care) monitoring/ per protocol/ else) in the operating room
2. Evaluate whether there are factors in transfusion therapy that are associated with outcome (in-hospital mortality and unplanned admission to ICU(Intensive Care Unit).)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6066
- patients undergoing elective non-cardiac surgery commencing during the three-month period and who received at least one erythrocyte concentrate during their intra-operative stay.
- Age < 18 years
- cardiothoracic surgery
- emergency trauma patients
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of PRBC and blood products and coagulation factors transfused The Time point at which outcome measure is assessed is during surgery at Day 0 Amount of packed red blood cells and blood products and coagulation factors: fresh frozen plasmas (FFPs), platelets (PTs) and tranexamic acid transfused
- Secondary Outcome Measures
Name Time Method Factors determining transfusion of PRBC and blood products in different regions of Europe The Time point at which outcome measure is assessed is during surgery at Day 0 Reasons for transfusion of PRBC(packed red blood cells)and blood products in different regions of Europe
30-day mortality The Time point at which outcome measure is assessed is at Day 30 after Surgery Assesses on Day 30 whether patient is still alive or has died between day zero (Surgery) day 30 after surgery
Type and frequency of usage of blood conserving techniques The Time point at which outcome measure is assessed is at Day 0, on Surgery Day Unplanned admission to the ICU The Time point at which outcome measure is assessed is at Day 30 after Surgery Assesses on day 30 whether the patient had a Unplanned admission to the Intensive care unit(ICU) following surgery (day 0) until the day 30
Trial Locations
- Locations (9)
University hospital "Merkur"
🇭🇷Zagreb, Croatia
Faculty Hospital Brno
🇨🇿Brno, Czechia
Hospital Vall d Hebron
🇪🇸Barcelona, Spain
Aretaieion University Hospital
🇬🇷Athens, Greece
University Hospital Tübingen University, Germany
🇩🇪Tübingen, Germany
Sahlgrenska University Hospital
🇸🇪Göteborg, Sweden
Hospital Clínico Universitario de Valencia
🇪🇸Valencia, Spain
Tel Aviv Medical Center
🇮🇱Tel Aviv, Israel
North Estonian Center
🇪🇪Tallinn, Estonia